References
- Vogl T, Gharibyan AL, Morozova-Roche LA. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci. 2012;13:2893–2917.
- Korndörfer IP, Brueckner F, Skerra A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J Mol Biol. 2007;370:887–898.
- Fagerhol MK, Nielsen HG, Vetlesen A, et al. Increase in plasma calprotectin during long-distance running. Scand J Clin Lab Invest. 2005;65:211–220.
- Stríz I, Trebichavský I. Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245–253.
- Ghavami S, Chitayat S, Hashemi M, et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol. 2009;625:73–83.
- Damo SM, Kehl-Fie TE, Sugitani N, et al. Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc Natl Acad Sci USA. 2013;110:3841–3846.
- Voganatsi A, Panyutich A, Miyasaki KT, et al. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol. 2001;70:130–134.
- Tardif MR, Chapeton-Montes JA, Posvandzic A, et al. Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux. J Immunol Res. 2015;2015:1–16.
- Holmgaard DB, Mygind LH, Ingrid T, et al. Calprotectin — a marker of mortality in COPD? Results from a prospective cohort study. COPDJ Chron Obstruct Pulmon Dis. 2013;10:581–587.
- Abildtrup M, Kingsley GH, Scott DL. Calprotectin as a biomarker for rheumatoid arthritis: a systematic review. J Rheumatol. 2015;42:760–770.
- Pepper RJ, Draibe JB, Caplin B, et al. Association of serum calprotectin (S100A8/A9) level with disease relapse in proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2017;69:185–193.
- Gao S, Yang Y, Fu Y, et al. Diagnostic and prognostic value of myeloid-related protein complex 8/14 for sepsis. Am J Emerg Med. 2015;33:1278–1282.
- Terrin G, Passariello A, Manguso F, et al. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin Dev Immunol. 2011;2011:291085.
- Jonsson N, Nilsen T, Gille-Johnson P, et al. Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment. Crit Care Resusc. 2017;19:205–213.
- Henderson P, Casey A, Lawrence SJ, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol. 2012;107:941–949.
- Herrera OR, Christensen ML, Helms RA. Calprotectin: clinical Applications in Pediatrics. J. Pediatr Pharmacol Ther. 2016;21:308–321.
- Nilsen T, Sunde K, Larsson A. A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers. J Inflamm. 2015;12:45.
- Chesher D. Evaluating assay precision. Clin Biochem Rev. 2008;29 Suppl 1:S23–S26.
- Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. Clin Chem Lab Med. 1983;21:709–720.
- Clinical and Laboratory Standards Institute. Defining, establishing and verifying reference intervals in the clinical laboratory; Approved Guideline, CLSI document C28-A3c. 3rd ed. Wayne, PA: CLSI; 2008; p. 24–27.
- Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem. 1971;17:275–284.
- Ricós C, Alvarez V, Cava F, et al. Current databases on biologic variation: pros, cons, and progress. Scand J Clin Lab Invest. 1999;59:491–500. Updated 2014 at: http://www.westgard.com/biodatabase1.htm. Accessed: 31 May 2018.
- Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand J Clin Lab Invest. 1990;50:837–841.
- Pedersen L, Birkemose E, Gils C, et al. Sample type and storage conditions affect calprotectin measurements in blood. J App Lab Med. . 2018;2:851–856.
- Nilsen T, Sunde K, Hansson L-O, et al. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. J Clin Lab Anal. 2017;31:e22061.
- Linnet K. Two-stage transformation systems for normalization of reference distributions evaluated. Clin Chem. 1987;33:381–386.